Trial intelligence / Profile preview

Effect of omega-3-rich parenteral nutrition on cellular immune defense in postoperative patients

2005-004492-37Phase 4Completed

Sponsor
Klinik für Anästhesiologie
Start
Nov 2005
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, single-arm trial of SMOFlipid, sponsored by Klinik für Anästhesiologie. Primary endpoints: Granulocyte cellular function by phagocytosis test and Granulocyte respiratory burst. Started Nov 2005; status: completed.

02

Drugs

SMOFlipid

Beyond the preview

Go deeper on 2005-004492-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004492-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call